Product Information
Registration Status: ActiveSIN03711P
UROGESIC TABLET 100mg is approved to be sold in Singapore with effective from 1989-06-10. It is marketed by ATLANTIC PHARMACEUTICAL (S) PTE LTD, with the registration number of SIN03711P.
This product contains Phenazopyridine 100mg in the form of TABLET, SUGAR-COATED. It is approved for ORAL use.
This product is manufactured by ATLANTIC LABORATORIES CORPN LTD in THAILAND.
It is an Over-the-counter Medicine that can be freely obtained from any retailer
Product Reference
Important Note: For generic product, the SPC/PIL provided may not be brand specific.
{{/items}} {{^items}}Description
A local anesthetic that has been used in urinary tract disorders. Its use is limited by problems with toxicity (primarily blood disorders) and potential carcinogenicity. [PubChem]
Indication
For the symptomatic relief of pain, burning, urgency, frequency, and other discomforts arising from irritation of the lower urinary tract mucosa caused by infection, trauma, surgery, endoscopic procedures, or the passage of sounds or catheters.
Mechanism of Action
Phenazopyridine's mechanism of action is not well known, and only basic information on its interaction with the body is available. It is known that the chemical has a direct topical analgesic effect on the mucosa lining of the urinary tract.
Toxicity
Methemoglobinemia generally follows a massive, acute overdose.
Active Ingredient/Synonyms
3-(Phenylazo)-2,6-pyridinediamine | Fenazopiridina | Phenazopyridine |
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.